Lazarini et al. [13] discovered that ARHGAP21 could regulate the proliferation and the migration of PC3 cells representing advanced prostate cancer, whereas the migration of LNCaP cells representing early prostate cancer was not affected, suggesting that ARHGAP21 may play different roles in different stages of prostate cancer. This evidence concerns the gene ARHGAP21 and prostate carcinoma.